ロード中...
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia
Standard treatment for hairy cell leukemia (HCL) is markedly effective, but the constant decrease in disease-free survival, together with the presence of minimal residual disease (MRD), suggests that few if any are cured. HCL cells in MRD are always strongly CD20+ and CD22+, and also CD25 + unless t...
保存先:
| 出版年: | Leuk Lymphoma |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435070/ https://ncbi.nlm.nih.gov/pubmed/21599609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.565843 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|